Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 7.63 +0.14 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.49 | 52 Week High | $7.49 | |||
| Open | $7.63 | 52 Week Low | $2.61 | |||
| Day High | $7.72 | P/E | N/A | |||
| Day Low | $7.58 | EPS | $-1.10 | |||
| Volume | 53,202 | |||||
| (NASDAQ: GANX) | Delayed: 2.02 +0.04 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.98 | 52 Week High | $ | |||
| Open | $1.98 | 52 Week Low | $ | |||
| Day High | $2.02 | P/E | N/A | |||
| Day Low | $1.98 | EPS | $ | |||
| Volume | 11,657 | |||||
